UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040740
Receipt number R000046512
Scientific Title Comparative study on LDL-cholesterol level using powdered green tea
Date of disclosure of the study information 2020/06/12
Last modified on 2020/11/25 08:37:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparative study on LDL-cholesterol level using powdered green tea

Acronym

Comparative study on LDL-cholesterol level using powdered green tea

Scientific Title

Comparative study on LDL-cholesterol level using powdered green tea

Scientific Title:Acronym

Comparative study on LDL-cholesterol level using powdered green tea

Region

Japan


Condition

Condition

Healthy adult

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effects of the intake of test food on LDL-cholesterol level

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

serum lipid

Key secondary outcomes

waist circumference, body fat percentage, blood glucose level, blood pressure, safety


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Intake of test food for 12 consecutive weeks

Interventions/Control_2

Intake of placebo food for 12 consecutive weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

69 years-old >=

Gender

Male and Female

Key inclusion criteria

(1) Males and females from 20 to 64 years of age
(2) Serum LDL- cholesterol level are ranged from 120 mg/dL to 139 mg/dL
(3) Preferentially select women with menopause or stable menstrual cycle

Key exclusion criteria

(1) Subjects who routinely take foods or medicines affecting the test result
(2) Subjects with fasting triglyceride value of 400 mg/dL or more
(3) Subjects who have a disease requiring regular medication or a history of serious diseases for which medication was required
(4) Subjects who have under treatment or a history of serious disease (e.g., diabetes, or liver disease, kidney disease, or heart disease)
(5) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire
(6) Subjects having possibilities for emerging allergy related to the study
(7) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination
(8) Subjects participating in other clinical study
(9) Females who are known or suspected to be pregnant, breastfeeding or desire to become pregnant during the trial period
(10) Subjects who are judged unfit to enroll in this trial by the investigator

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Masaharu
Middle name
Last name Ohkawara

Organization

Satoen Co., LTD.

Division name

none

Zip code

421-1392

Address

1057 Ohhara, Aoi-ku, Shizuoka, Japan

TEL

054-270-1336

Email

masaharu-ohkawara@satoen.co.jp


Public contact

Name of contact person

1st name Shinsuke
Middle name
Last name Tsuji

Organization

TTC Co., Ltd.

Division name

Clinical Research Planning Department

Zip code

150-0021

Address

Seibu Shinkin Bank Ebisu Bldg.,1-20-2, Ebisunishi, Shibuya-ku, Tokyo

TEL

03-5459-5329

Homepage URL


Email

s.tsuji@ttc-tokyo.co.jp


Sponsor or person

Institute

TTC Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Satoen Co., LTD.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Medical Station Clinic Research Ethics Committee

Address

3-12-8, Takaban, Meguroku, Tokyo

Tel

03-6452-2712

Email

t.saito@ttc-smo.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 06 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 05 Month 28 Day

Date of IRB

2020 Year 05 Month 28 Day

Anticipated trial start date

2020 Year 06 Month 15 Day

Last follow-up date

2020 Year 10 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 06 Month 12 Day

Last modified on

2020 Year 11 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046512


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name